1002 related articles for article (PubMed ID: 14658397)
1. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
[TBL] [Abstract][Full Text] [Related]
2. [Relation between autonomic dysfunction and progression of Parkinson's disease].
Oka H; Mochio S; Inoue K
Rinsho Shinkeigaku; 2001 Jun; 41(6):283-8. PubMed ID: 11771156
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of orthostatic hypotension in Parkinson's disease.
Oka H; Yoshioka M; Onouchi K; Morita M; Mochio S; Suzuki M; Hirai T; Ito Y; Inoue K
Brain; 2007 Sep; 130(Pt 9):2425-32. PubMed ID: 17673498
[TBL] [Abstract][Full Text] [Related]
4. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy.
Oka H; Mochio S; Yoshioka M; Morita M; Onouchi K; Inoue K
Acta Neurol Scand; 2006 Apr; 113(4):221-7. PubMed ID: 16542160
[TBL] [Abstract][Full Text] [Related]
6. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
[TBL] [Abstract][Full Text] [Related]
7. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
8. Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease.
Suzuki M; Nakamura T; Hirayama M; Ueda M; Katsuno M; Sobue G
J Neurol; 2017 Feb; 264(2):333-340. PubMed ID: 27900499
[TBL] [Abstract][Full Text] [Related]
9. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M
J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697
[TBL] [Abstract][Full Text] [Related]
10. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
[TBL] [Abstract][Full Text] [Related]
11. Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson's disease.
Oka H; Toyoda C; Yogo M; Mochio S
J Neural Transm (Vienna); 2011 Sep; 118(9):1323-7. PubMed ID: 21331459
[TBL] [Abstract][Full Text] [Related]
12. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
[TBL] [Abstract][Full Text] [Related]
13. [123 I-MIBG myocardial sympathetic innervation scintigraphy and Parkinson's disease. Preliminary results].
Jiménez-Hoyuela JM; Rebollo AC; Campos V; Rius F
Rev Esp Med Nucl; 2003; 22(4):229-37. PubMed ID: 12846947
[TBL] [Abstract][Full Text] [Related]
14. Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease.
Oka H; Yoshioka M; Morita M; Onouchi K; Suzuki M; Ito Y; Hirai T; Mochio S; Inoue K
Neurology; 2007 Oct; 69(14):1460-5. PubMed ID: 17909159
[TBL] [Abstract][Full Text] [Related]
15. Systemic blood pressure profile correlates with cardiac 123I-MIBG uptake in patients with Parkinson's disease.
Manabe Y; Fujii D; Kono S; Sakai Y; Tanaka T; Narai H; Omori N; Imai Y; Abe K
J Neurol Sci; 2011 Aug; 307(1-2):153-6. PubMed ID: 21640359
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the relationship between muscle sympathetic nerve activity and cardiac 123I-metaiodobenzylguanidine uptake in patients with Parkinson's disease.
Shindo K; Kaneko E; Watanabe H; Sugimoto T; Ohta E; Ohashi K; Nagasaka T; Shiozawa Z
Mov Disord; 2005 Nov; 20(11):1419-24. PubMed ID: 16007621
[TBL] [Abstract][Full Text] [Related]
17. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
[TBL] [Abstract][Full Text] [Related]
18. [Early alteration of adrenergic cardiac function in parkinsonisms with Lewy bodies].
Jiménez-Hoyuela García JM; Campos Arillo V; Rebollo Aguirre AC; Gómez Doblas JJ; Gutiérrez Hurtado A
Rev Esp Med Nucl; 2005; 24(2):93-100. PubMed ID: 15745679
[TBL] [Abstract][Full Text] [Related]
19. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.
Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K
J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675
[TBL] [Abstract][Full Text] [Related]
20. Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms.
Rocchi C; Pierantozzi M; Galati S; Chiaravalloti A; Pisani V; Prosperetti C; Lauretti B; Stampanoni Bassi M; Olivola E; Schillaci O; Stefani A
CNS Neurosci Ther; 2015 Sep; 21(9):727-32. PubMed ID: 26205884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
